Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001620524-17-000001
Filing Date
2017-05-24
Accepted
2017-05-24 17:20:27
Documents
1
Effectiveness Date
2017-05-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5623
  Complete submission text file 0001620524-17-000001.txt   6646
Mailing Address 4939 SW 91ST DRIVE GAINESVILLE FL 32608
Business Address 4939 SW 91ST DRIVE GAINESVILLE FL 32608 904-599-3264
NeXtGen Biologics, INC (Filer) CIK: 0001620524 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-265199 | Film No.: 17867586